Science

Engineered albumin helps a therapeutic protein last longer and cross mucosal barriers

Source: Phys.org · Published 28 Oct 2026, 10:00

Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the bloodstream. For patients who depend on long-term or lifelong treatment, frequent injections place a considerable burden on everyday life.

We are a news aggregator: we show the headline and a short excerpt with a link to the original source. We never republish full articles.